Cargando…
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
Recent clinical data with three therapeutic anti-Aβ antibodies have demonstrated that removal of Aβ-amyloid plaques in early Alzheimer's disease (AD) can attenuate disease progression. This ground-breaking progress in AD medicine has validated both the amyloid cascade hypothesis and Aβ-amyloid...
Autores principales: | Nordvall, Gunnar, Lundkvist, Johan, Sandin, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613654/ https://www.ncbi.nlm.nih.gov/pubmed/37908487 http://dx.doi.org/10.3389/fnmol.2023.1279740 |
Ejemplares similares
-
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
por: Tate, Barbara, et al.
Publicado: (2012) -
γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
por: Weber, Tobias A., et al.
Publicado: (2021) -
The battle of Alzheimer’s Disease – the beginning of the future Unleashing the potential of academic discoveries
por: Lundkvist, Johan, et al.
Publicado: (2014) -
β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease
por: Menting, Kelly Willemijn, et al.
Publicado: (2014) -
A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)